ENHANCED GENOMICS LIMITED
Significant control: Bgf Investment Management Limited (25–50%), Mnl (Parkwalk) Nominees Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Enhanced Genomics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Enhanced Genomics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ENHANCED GENOMICS LIMITED is an active private limited company (company number 12423696) incorporated on 24 January 2020, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.
There are 196 companies in research and experimental development on biotechnology in Cambridge with filed accounts; the median reports net assets of £15k and is 7 years old.
Ownership and control
- Bgf Investment Management Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mnl (Parkwalk) Nominees Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Mikhail Spivakov
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Prof Peter John Fraser
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Stefan Walter Schoenfelder
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Prof Peter John Fraser
- owns 25–50% of shares
- holds 25–50% of voting rights
- Bioqube Factory Fund I Commv
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 January 20206 yrs ago
- First accounts due
- 24 October 20211827 days overdue
- Confirmation statement due
- 7 February 2027in 105 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
Financials
Accounts exist on the register but their figures are not in this dataset yet.
Filing and accounts signals
- Incorporated five or more years agoIncorporated 24 January 2020
- Accounts past their due dateDue 24 October 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 105 days
- First accounts due1827 days overdue
- Incorporated
Similar companies in Cambridge
- BROKEN STRING BIOSCIENCES LIMITEDSaffron Walden · inc. Jan 2020
- BIOCERA MEDICAL LIMITEDHaverhill · inc. Jan 2020
- IMHOTEX LIMITEDCambridge · inc. Feb 2020
- MESTAG THERAPEUTICS LTDSaffron Walden · inc. Feb 2020
- AVATRIAL LTDCambridge · inc. Dec 2019
- LUCIDA MEDICAL LTDCambridge · inc. Nov 2019
All companies incorporated on 24 January 2020 · in Jan 2020.
Reminders for ENHANCED GENOMICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.